WVE Q1 2023 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$13M+638.8% YoY

Gross Profit

-$18M-139.6% margin

Operating Income

-$30M-234.2% margin

Net Income

-$27M-212.0% margin

EPS (Diluted)

$-0.24

QoQ Revenue Growth

+943.5%

Cash Flow

Operating Cash Flow

$86M

Free Cash Flow

$85M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$267M

Total Liabilities

$302M

Stockholders' Equity

-$35M

Cash & Equivalents

$208M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$2M	+638.8%
Gross Profit	-$18M	-$26M	+29.8%
Operating Income	-$30M	-$38M	+20.5%
Net Income	-$27M	-$38M	+27.5%